BOSTON — June 8, 2021 — Tausight today announced the appointment of Paymon Farazi as its chief product officer (CPO). Farazi brings more than 20 years of product leadership experience to his new role at Tausight, where he will be responsible for building out the company’s healthcare-specific platform for exposing the hidden vulnerabilities in clinical workflows that can put patients’ protected health information (PHI) at risk.
“Protecting patient data requires real-time visibility and advanced analytics to accurately determine how patients’ PHI is being used and transmitted across clinical workflows and into private cloud environments. Tausight’s mission is to give healthcare CIOs and CISOs the ability to see where hidden PHI is uniquely vulnerable and help preemptively mitigate their risk before a security incident occurs,” said Dave Dickinson, CEO of Tausight. “Paymon’s deep experience in developing Artificial Intelligence and Machine-Learning-driven healthcare analytics will be critical in helping us bring to market an entirely new approach to better protecting PHI within a broad diversity of in-hospital and virtual care clinical workflows.”
As CPO, Farazi’s experience overseeing products built around large data sets while harnessing Machine Learning and Artificial Intelligence will help Tausight realize its vision of enabling healthcare security teams to identify and secure PHI wherever clinical care leads. As more PHI goes into private clouds and remote locations as a result of digital transformation and the acceleration of virtual care, Tausight will help healthcare institutions better protect PHI and their clinicians through a breakthrough platform that will be focused solely on better securing clinical workflow.
Previously, Farazi was the CPO at OptumInsight, an $11B division of Optum/UnitedHealth Group. Prior to Optum, Farazi served in leadership positions across industries at companies including Cargill, Symantec, and at Dell’s multi-billion-dollar Enterprise Networking and Storage business. He is Tausight’s first C-suite hire after CEO Dave Dickinson, joining on the heels of Tausight’s $20 million Series A funding in March 2021.
“PHI is incredibly difficult to secure in a complex environment like healthcare, which requires a comprehensive understanding of how and where PHI flows and where it resides,” said Paymon Farazi, CPO of Tausight. “Designed from the ground up specifically for healthcare environments, Tausight will provide the platform healthcare institutions need to truly take a preemptive approach to identifying and securing PHI across clinical workflows.”